Though the materials in subsets are small, women with KRAS mutant rectal cancers were diagnosed mean 10 years earlier (mean age 48, range 25-71, years) than those with KRAS wild-type rectal cancers (mean age 58, range 52-70, years). This evidence concerns the gene KRAS and rectal cancer.